Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.215
-0.040 (-1.77%)
Feb 9, 2026, 11:15 AM EST - Market open
BDTX Market Cap
BDTX has a market cap or net worth of $126.2 million as of February 9, 2026. Its market cap has decreased by -10.79% in one year.
Market Cap
126.20M
Enterprise Value
12.65M
1-Year Change
-10.79%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $126.20M, a decrease of -90.69%. That is a compound annual growth rate of -32.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 128.48M | -7.20% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cibus | 140.52M |
| Connect Biopharma Holdings | 138.08M |
| Spero Therapeutics | 136.34M |
| Oramed Pharmaceuticals | 135.73M |
| Sutro Biopharma | 131.82M |
| Fate Therapeutics | 130.92M |
| Whitehawk Therapeutics | 130.07M |
| Seres Therapeutics | 126.65M |